1 Dividend Stock Down 30% to Buy and Hold for the Next Decade

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) saw its fortunes reversed last year. Though the drugmaker had performed well since the beginning of the decade, it encountered issues that sank its stock price, mostly related to one of its biggest growth drivers (more on tha https://www.nasdaq.com/articles/1-dividend-stock-down-30-buy-and-hold-next-decade